Bangalore, India -- (SBWIRE) -- 07/20/2017 -- General Report Contents

- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions

The primary driver for sales in oxygen therapy devices is the move within the market from traditional cylinder-based methods of oxygen delivery (such as transfilling or oxygen delivery) to portable concentrating technology. While the portable concentrators will always be a more expensive up-front cost to providers, the long-term cost benefit versus alternative methods is apparent. Limiting this switch has been the incentives put into place by Medicare's Competitive Bidding Program.

Most oxygen therapy clients are covered by some sort of insurance policy, with the vast majority of clients falling under Medicare coverage. The market for DME (durable manufactured equipment), including oxygen therapy items, is set up in the United States so that patients rent the device from the supplier for which they pay a percentage of the cost monthly with the insurer paying the residual amount. Thus in turn, insurance companies have large influences over the products that are pushed in the market. The high cost of concentrators has been limiting as a result, which is why less convenient oxygen cylinders persisted to be a larger market for years.

More portable devices are considered the next generation of oxygen therapy as they allow patients to be more mobile and independent. This is set to generate demand as it improves the lifestyle of patients diagnosed with conditions which require oxygen therapy.

Oxygen therapy patients require a number of devices in the long term to treat their condition. Overall, the oxygen therapy market is broken down into six types of devices: concentrators, liquid oxygen, conservers, regulators, transfilling devices and aluminum medical oxygen cylinders. Concentrators and oxygen cylinders are the two main devices that deliver oxygen to patients while transfilling devices, regulators and conservers are used alongside a cylinder as a secondary component.

Spanning over 263 pages "US Market Report for Oxygen Therapy 2017 - MedCore" report covers Executive Summary, Research Methodology, Product Assessment, Oxygen Therapy Market, Appendix. This Report Covered Companies Few Are - Philips Respironics, Resmed, Caire Inc., Becton Dickinson, Ge Healthcare, Covidien, Devilbiss, Invacare, Dr?ger, Teleflex, Fisher & Paykel, Inogen, Smiths Medical.

For more information Visit at: http://www.drugpipeline.net/idata-research/us-market-report-oxygen-therapy-2017-medcore

Find all Pharma and Healthcare Reports at - http://www.drugpipeline.net/catalog/pharma-healthcare

Related Reports;

US Market Report for Nebulizers 2017 - MedCore - Visit at - http://www.drugpipeline.net/idata-research/us-market-report-nebulizers-2017-medcore

US Market Report for Sleep Diagnostic Devices 2017 - MedCore - Visit at - http://www.drugpipeline.net/idata-research/us-market-report-sleep-diagnostic-devices-2017-medcore

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.